Wedbush Securities’s Intersect ENT, Inc XENT Stock Holding History

Wedbush Securities’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,200	Closed	-$123K	–	896
2016 Q4	$123K	Buy	+10,200	New	+$132K	0.02%	726

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Wedbush Securities's XENT Position: Q1 2017 in Review

Wedbush Securities sold out of Intersect ENT, Inc (XENT) in Q1 2017, closing a stake of 10,200 shares — an estimated $123K sold.

Wedbush Securities first reported a position in XENT in Q4 2016 and held it in 1 quarter. The position peaked at $123K in Q4 2016. 106 funds tracked by Wall St. Rank hold XENT as of Q1 2017.

Wedbush Securities reported no remaining Intersect ENT, Inc position as of Q1 2017 after selling out during the quarter.
Wedbush Securities sold 10,200 Intersect ENT, Inc shares in Q1 2017, an estimated $123K.
Wedbush Securities first reported a position in Intersect ENT, Inc in Q4 2016 and held it in 1 quarter.
Wedbush Securities's Intersect ENT, Inc position peaked at $123K in Q4 2016.
106 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2017.

Based on Wedbush Securities's 13F filing for Q1 2017, filed 5 May 2017.